Bausch + Lomb (NYSE:BLCO) announced today that it launched an offering worth $1.4 billion in new senior secured notes. The company intends to offer the notes, due 2028, and to enter into an incremental term loan facility. Both moves aim to support the financing of the company’s pending acquisition of XIIDRA. Bausch + Lomb expects […]
Vision
Zeiss to unveil new intraocular lens, other ophthalmic tech
Zeiss Medical Technology intends to unveil new ophthalmic innovations within its cataract and corneal refractive workflows. The Carl Zeiss Meditec unit plans to showcase these technologies at the European Society of Cataract and Refractive Surgery conference next month. As part of its ecosystem, the new offerings bolster Zeiss’ leadership position in ophthalmic diagnostic and surgical […]
Staar Surgical, NFL QB Will Levis team up to promote implantable collamer lenses
Staar Surgical (Nasdaq:STAA) announced today that it partnered with Tennessee Titans quarterback Will Levis to promote the EVO ICL. EVO Implantable Collamer lenses (ICLs) work in harmony with the natural eye to provide clear vision without causing dry eye. The FDA-approved lenses correct myopia, which affects distance vision, and myopia with astigmatism, which causes blurred […]
Eyenovia makes first sale of drug-device combo for pupil dilation
Eyenovia (Nasdaq:EYEN) today announced the first commercial sale of Mydcombi, its eye treatment for use with the Optejet delivery device. In May, the FDA approved the Mydcombi treatment for use with Optejet. New York-based Eyenovia designed Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short-term […]
Glaukos beats Wall Street sales expectations in Q2
Glaukos (NYSE:GKOS) shares posted second-quarter financial results that came in well ahead of the consensus revenue forecast. Shares of GKOS remained relatively unmoved at $74.72 apiece after the market closed today. The Aliso Viejo–based ophthalmic medical technology company posted losses of $32.8 million. That amounts to 68¢ per share on sales of $80.4 million for […]
Glaukos agrees to market Radius XR’s wearable diagnostics in the U.S.
Glaukos (NYSE:GKOS) announced today that it entered into a collaboration and marketing agreement with Radius XR. Aliso Viejo, California-based Glaukos becomes the exclusive sales agent for the Radius XR wearable patient engagement and diagnostic system. The agreement gives the company the rights to market, promote and solicit orders for the platform in the U.S. Under […]
Bausch + Lomb makes another eye drop acquisition
Bausch + Lomb (NYSE:BLCO) announced today that an affiliate purchased the Blink product line from Johnson & Johnson Vision. The over-the-counter Blink product line features eye and contact lens drops, marking another eye care acquisition for Bausch + Lomb. Last week, the company acquired eye drops and a delivery system from Novartis in a deal worth up to […]
Bausch + Lomb acquires XIIDRA eye drops, delivery system from Novartis in $2.5B deal
Bausch + Lomb (NYSE:BLCO) announced today that it agreed to acquire XIIDRA non-steroid eye drops from Novartis. The company also acquired an investigational medicine and rights to a delivery device for treating dry eye disease (DED). AcuStream, an investigational device that may have the potential to facilitate precise dosing and accurate delivery of certain topical […]
Luminopia raises $16M for digital lazy eye therapeutic
Luminopia announced that it raised $16 million to support its software-based therapeutic for amblyopia, commonly known as lazy eye. Cambridge, Massachusetts-based Luminopia saw its oversubscribed Series A financing round led by U.S. Venture Partners (USVP). New investor Broadfin Advisors supported alongside existing investors ShangBay Capital and Vertical Group. In conjunction with the financing. USVP General […]
Precision Lens, owner hit with $487M judgement in kickbacks case
A U.S. District Judge entered a judgment against Precision Lens and its owner, Paul Ehlen, for more than $487 million in a kickback case. Judge Wilhelmina M. Wright’s decision follows a verdict handed down by a federal jury in Minnesota earlier this year. The jury concluded that the defendants violated the False Claims Act and […]
FDA approves ophthalmic spray from Eyenovia
Eyenovia (Nasdaq:EYEN) announced today that the FDA approved its Mydcombi treatment for use with the Optejet delivery device. New York-based Eyenovia designed Mydcombi (tropicamide and phenylephrine hydrochloride ophthalmic spray) 1%/2.5% for inducing mydriasis for diagnostic procedures and in conditions where short-term pupil dilation is desired. It marks the first approved fixed-dose combination of tropicamide and […]
